Global Report: People Problems - Pharmaceutical Executive


Global Report: People Problems
A recent clinical trials disaster is causing UK regulators to consider revising its guidelines for Phase I human studies for biologics. However, in many cases, potential solutions present additional problems.

Pharmaceutical Executive

Sarah Houlton, PhD, is Pharmaceutical Executive's global correspondent. She can be reached at


blog comments powered by Disqus

Source: Pharmaceutical Executive,
Click here